High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma: Complete Remission at Transplantation Is the Major Determinant of Outcome—Lymphoma Working Party of the European Group for Blood and Marrow TransplantationCharalampia Kyriakou, Norbert Schmitz, Dolores Caballero et al.|Journal of Clinical Oncology|2007Cited by 155
Reduced‐intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long‐term outcomesKarl S. Peggs, Anna Sureda, Wendi Qian et al.|British Journal of Haematology|2007Cited by 106